The data itself in the RespiStimALS trial does indicate, as near as I can tell, a need for the RespiStimALS trial termination; instead the trial ended because the DiPALS trial problems, which possibly an indication of an undetected risk. Quite a lot of time has passed with no particular case injury reported. There is a new trial posted regarding the pacer.